![]()
|
|
||||||||
J. Biol. Chem., Vol. 277, Issue 36, 32985-32991, September 6, 2002
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Pathway
,
,
,
,
, and
§**
From the Departments of We hypothesize that in neurodegenerative
disorders such as Alzheimer's disease and human immunodeficiency
virus encephalitis the neuroprotective activity of fibroblast
growth factor 1 (FGF1) against several neurotoxic agents might involve
regulation of glycogen synthase kinase-3
Neurosciences and
§ Pathology, University of California San Diego, La Jolla,
California 92093-0624, the ¶ Section of Experimental
Neuropathology and Psychiatry, Institute of Psychiatry, London SE5 8AF,
United Kingdom, and
The Burnham Institute, Center for
Neuroscience and Aging, La Jolla, California 92037
(GSK3
), a pathway
important in determining cell fate. In primary rat neuronal and HT22
cells, FGF1 promoted a time-dependent inactivation of
GSK3
by phosphorylation at serine 9. Blocking FGF1 receptors with
heparinase reduced this effect. The effects of FGF1 on GSK3
were
dependent on phosphatidylinositol 3-kinase (PI3K)-protein kinase B
(Akt) because inhibitors of this pathway or infection with dominant
negative Akt adenovirus blocked inactivation. Furthermore, treatment of
neuronal cells with FGF1 resulted in ERK-independent Akt
phosphorylation and
-catenin translocation into the nucleus. On the
other hand, infection with wild-type GSK3
recombinant
adenovirus-associated virus increased activity of GSK3
and cell
death, both of which were reduced by FGF1 treatment. Moreover, FGF1
protection against glutamate toxicity was dependent on GSK3
inactivation by the PI3K-Akt but was independent of ERK. Taken together
these results suggest that neuroprotective effects of FGF1 might
involve inactivation of GSK3
by a pathway involving activation of
the PI3K-Akt cascades.
This article has been cited by other articles:
![]() |
M. B. Joshi, D. Ivanov, M. Philippova, P. Erne, and T. J. Resink Integrin-linked kinase is an essential mediator for T-cadherin-dependent signaling via Akt and GSK3{beta} in endothelial cells FASEB J, October 1, 2007; 21(12): 3083 - 3095. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Ito, Y. Nagayasu, K. Okumura-Noji, R. Lu, T. Nishida, Y. Miura, K. Asai, A. Kheirollah, S. Nakaya, and S. Yokoyama Mechanism for FGF-1 to regulate biogenesis of apoE-HDL in astrocytes J. Lipid Res., September 1, 2007; 48(9): 2020 - 2027. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Rockenstein, M. Torrance, A. Adame, M. Mante, P. Bar-on, J. B. Rose, L. Crews, and E. Masliah Neuroprotective Effects of Regulators of the Glycogen Synthase Kinase-3{beta} Signaling Pathway in a Transgenic Model of Alzheimer's Disease Are Associated with Reduced Amyloid Precursor Protein Phosphorylation J. Neurosci., February 21, 2007; 27(8): 1981 - 1991. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. I. Danek, J. Tcherkezian, I. Triki, M. Meriane, and N. Lamarche-Vane Glycogen Synthase Kinase-3 Phosphorylates CdGAP at a Consensus ERK 1 Regulatory Site J. Biol. Chem., February 9, 2007; 282(6): 3624 - 3631. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Rosas, P. F. Dijkers, C. L. Lindemans, J.-W. J. Lammers, L. Koenderman, and P. J. Coffer IL-5-mediated eosinophil survival requires inhibition of GSK-3 and correlates with {beta}-catenin relocalization J. Leukoc. Biol., July 1, 2006; 80(1): 186 - 195. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Ohyama, O. A. Mohamed, M. M. Taketo, D. Dufort, and A. K. Groves Wnt signals mediate a fate decision between otic placode and epidermis Development, March 1, 2006; 133(5): 865 - 875. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Qi, J. Wang, O. Romanyuk, and C.-H. Siu Involvement of Src Family Kinases in N-Cadherin Phosphorylation and beta-Catenin Dissociation during Transendothelial Migration of Melanoma Cells Mol. Biol. Cell, March 1, 2006; 17(3): 1261 - 1272. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-i. Ito, Y. Nagayasu, R. Lu, A. Kheirollah, M. Hayashi, and S. Yokoyama Astrocytes produce and secrete FGF-1, which promotes the production of apoE-HDL in a manner of autocrine action J. Lipid Res., April 1, 2005; 46(4): 679 - 686. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Cappuccio, A. Calderone, C. L. Busceti, F. Biagioni, F. Pontarelli, V. Bruno, M. Storto, G. T. Terstappen, G. Gaviraghi, F. Fornai, et al. Induction of Dickkopf-1, a Negative Modulator of the Wnt Pathway, Is Required for the Development of Ischemic Neuronal Death J. Neurosci., March 9, 2005; 25(10): 2647 - 2657. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Yuan, A. Agarwal-Mawal, and H. K. Paudel 14-3-3 Binds to and Mediates Phosphorylation of Microtubule-associated Tau Protein by Ser9-phosphorylated Glycogen Synthase Kinase 3{beta} in the Brain J. Biol. Chem., June 18, 2004; 279(25): 26105 - 26114. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Hashimoto, P. Bar-on, G. Ho, T. Takenouchi, E. Rockenstein, L. Crews, and E. Masliah {beta}-Synuclein Regulates Akt Activity in Neuronal Cells: A POSSIBLE MECHANISM FOR NEUROPROTECTION IN PARKINSON'S DISEASE J. Biol. Chem., May 28, 2004; 279(22): 23622 - 23629. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lyu and C.-K. Joo Wnt signaling enhances FGF2-triggered lens fiber cell differentiation Development, April 15, 2004; 131(8): 1813 - 1824. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. AVILA, J. J. LUCAS, M. PEREZ, and F. HERNANDEZ Role of Tau Protein in Both Physiological and Pathological Conditions Physiol Rev, April 1, 2004; 84(2): 361 - 384. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Zhang, J. Cheng, N. R. Hackett, G. Lam, K. Shido, R. Pergolizzi, D. K. Jin, R. G. Crystal, and S. Rafii Adenovirus E4 Gene Promotes Selective Endothelial Cell Survival and Angiogenesis via Activation of the Vascular Endothelial-Cadherin/Akt Signaling Pathway J. Biol. Chem., March 19, 2004; 279(12): 11760 - 11766. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Conant, C. St. Hillaire, H. Nagase, R. Visse, D. Gary, N. Haughey, C. Anderson, J. Turchan, and A. Nath Matrix Metalloproteinase 1 Interacts with Neuronal Integrins and Stimulates Dephosphorylation of Akt J. Biol. Chem., February 27, 2004; 279(9): 8056 - 8062. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Morrison, A. J. Klingelhutz, and N. Raab-Traub Epstein-Barr Virus Latent Membrane Protein 2A Activates {beta}-Catenin Signaling in Epithelial Cells J. Virol., November 15, 2003; 77(22): 12276 - 12284. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Dou, K. Birusingh, J. Faraci, S. Gorantla, L. Y. Poluektova, S. B. Maggirwar, S. Dewhurst, H. A. Gelbard, and H. E. Gendelman Neuroprotective Activities of Sodium Valproate in a Murine Model of Human Immunodeficiency Virus-1 Encephalitis J. Neurosci., October 8, 2003; 23(27): 9162 - 9170. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Holnthoner, M. Pillinger, M. Groger, K. Wolff, A. W. Ashton, C. Albanese, P. Neumeister, R. G. Pestell, and P. Petzelbauer Fibroblast Growth Factor-2 Induces Lef/Tcf-dependent Transcription in Human Endothelial Cells J. Biol. Chem., November 22, 2002; 277(48): 45847 - 45853. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |